Alzheimer's disease (AD), the most common form of dementia in the elderly, was found to exhibit a trend toward a higher risk in females than in males through epidemiological studies. Therefore, we hypothesized that gender-related genetic risks could exist. To reveal the ones for late-onset AD (LOAD), we extended our previous genetic work on chromosome 10q (genomic region, 60 -107 Mb), and single nucleotide polymorphism (SNP)-based genetic association analyses were performed on the same chromosomal region, where the existence of genetic risk factors for plasma Ab42 elevation in LOAD was implied on a linkage analysis. Two-step screening of 1140 SNPs was carried out using a total of 1408 subjects with the APOE-13 * 3 genotype: we first genotyped an exploratory sample set (LOAD, 363; control, 337), and then genotyped some associated SNPs in a validation sample set (LOAD, 336; control, 372). Seven SNPs, spanning about 38 kb, in intron 9 of CTNNA3 were found to show multiple-hit association with LOAD in females, and exhibited more significant association on Mantel -Haenszel test (allelic P-values MH-F 5 0.000005945 -0.0007658). Multiple logistic regression analysis of a total of 2762 subjects (LOAD, 1313; controls, 1449) demonstrated that one of the seven SNPs directly interacted with the female gender, but not with the male gender. Furthermore, we found that this SNP exhibited no interaction with the APOE-14 allele. Our data suggest that CTNNA3 may affect LOAD through a female-specific mechanism independent of the APOE-14 allele.
INTRODUCTION
Alzheimer's disease (AD) is a neurodegenerative disorder clinically characterized by progressive cognitive deterioration and is the most common form of dementia in the elderly. Its neuropathological features are amyloid plaques [extracellular deposition of amyloid b-protein (Ab)] and neurofibrillary tangles (intracellular aggregation of highly phosphorylated microtubule-associated protein tau), which finally lead to synaptic loss and/or neuronal death.
Recent epidemiological studies on AD revealed genderrelated differences in its prevalence (1 -3) and incidence (4 -6) . Compared with males, females are more likely to develop AD, although results contradicting this gender difference have been reported (7 -9) . In blood mononuclear cells in AD, there are substantial gender differences in gene expression (10) . The plasma level of amyloid beta-protein 42 (Ab42), a major constituent of senile plaques, is significantly increased in females with mild cognitive impairment, a transitional state between normal aging and mild dementia (11) . In transgenic animal models of AD, gender-dependent accumulation and deposition of Ab42 and Ab40 have been observed (12 -15) . Moreover, there has been increasing research on gender-related genetic risk factors in AD: ACT (16), MPO (17, 18) , ACE (19) , ESR2 (20) , DSC1 (21) and ABCA1 (22) . Therefore, based on these findings, we hypothesized that gender-related genetic risk factors that modify Ab metabolism in late-onset AD (LOAD), which accounts for 95 -99% of AD, could exist.
We have paid a great deal of attention to chromosome 10q, especially because the existence of genetic risk factors for plasma Ab42 elevation in it was implied on linkage analysis of LOAD families (23) . Furthermore, through other genetic approaches, including genome-wide linkage screening of affected sib pairs (24) and candidate gene-based analysis of multiplex AD families (25) , chromosome 10q was strongly suggested to be the most prominent one for LOAD. Therefore, regarding a genomic region on chromosome 10q (60-107 Mb), we previously performed large-scale single nucleotide polymorphism (SNP)-based screening of a Japanese population to identify additional genetic risk factors to APOE (19q13.2), which is universally recognized as a major risk gene for the development of LOAD (OMIM þ107741). Consequently, we found that DNMBP, which is involved in synaptic vesicle recycling, was associated with LOAD with the APOE-13 Ã 3 genotype or lacking the APOE-14 allele in several sample sets (26) .
Interestingly, replicated evidence for a parent-of-origin effect of chromosome 10q was recently reported for LOAD (27, 28) , which suggests that gender-related genes such as imprinting genes could be responsible for the disease development. Here, in order to determine whether or not genderrelated loci associated with LOAD are present, our previous genetic work on chromosome 10q (26) was extended. Two sample sets for screening, Exploratory and Validation, comprising only APOE-13 Ã 3 subjects were prepared, which were used for a case -control association study after being stratified as to gender. We first genotyped the Exploratory set, and then genotyped some significantly associated SNPs in the Validation set. Through this stepwise screening, among the 1140 SNPs subjected to the exploratory screening, we finally found seven SNPs located in intron 9 of CTNNA3 that showed reproducible association with LOAD in females. These replicated SNPs were further examined by means of genotyping of all the subjects with all APOE genotypes (12 Ã 2, 12 Ã 3, 12 Ã 4, 13 Ã 3, 13 Ã 4 and 14 Ã 4), i.e. 1526 LOAD patients (female, 1103; male, 423) and 1666 controls (female, 998; male, 668), some of them exhibiting significance only in a female sub-sample set. In terms of biological functions, CTNNA3 (29, 30) , encoding a-T catenin, is thought to be a promising candidate for LOAD because it is a binding partner of b-catenin, which interacts with PSEN1 (31), and because it was recently shown to be associated with the level of plasma Ab42 in a set of families with LOAD (32) . Multiple logistic regression analysis in a total of 2762 subjects (LOAD, 1313; controls, 1449) revealed that one (SNP rs713250) of the seven associated SNPs exhibits a significant interaction with the female gender, but not with the male gender and the APOE-14 allele. Our data suggest that CTNNA3 could affect LOAD through a female-specific mechanism independent of the APOE-14 allele.
RESULTS

Allelic association
To determine whether gender-related loci associated with LOAD on chromosome 10q (60 -107 Mb) exist or not, we stratified the Exploratory sample set (Table 1) by gender, resulting in female and male subsets. An allelic contingency table (2 Â 2)-based x 2 test was performed using already-obtained genotype data (26) for 1140 SNPs for the Exploratory set. Calculation of allelic P-values and odds ratios (ORs) with 95% confidence interval (CI) was carried out to examine the genetic association of these SNPs. In a Japanese population, these SNPs were actually polymorphic and showed a P-value .0.05 in exact tests of Hardy -Weinberg equilibrium (HWE) in both cases and controls of the Exploratory set (details given under Materials and Methods). The results of x 2 tests for the gender-stratified sets are presented in Fig. 1 . In the female group (LOAD, 249; controls, 223), 106 of the 1140 SNPs had significant allelic P-values ,0.05, and 34 of these 106 showed more significant values (allelic P-values ,0.01). In the male group (LOAD, 114; controls, 114), 53 of the 1140 SNPs showed allelic P-values ,0.05, and 7 of these 53 showed more significant association with allelic P-values ,0.01.
A total of 41 SNPs (34 and 7 SNPs in female and male Exploratory sets, respectively) showing allelic P-values ,0.01 were further analyzed by means of x 2 tests to determine whether or not these SNPs actually exhibit reproducible allelic association using another sample set, Validation, sub-grouped as to gender (Table 1 ). In the male Validation set (LOAD, 94; controls, 159), three of the above-mentioned seven SNPs showed reproducible association (allelic P-values ¼ 0.0342 -0.046). Among these three SNPs, only SNP rs1000280 exhibited a significant value on Mantel-Haenszel test (allelic P-value MH-M ¼ 0.0009112). This SNP is located in the intergenic region between LOXL4 (100.00-100.02 Mb) and C10orf33 (100.13 -100.16 Mb); therefore, we did not (rs911541, rs3740066, rs11190302, rs35715207, rs3758394, rs3740058, rs3740057, rs11190315 and rs6584331) are located in a locus between ENTPD7 and DNMBP recently reported by our group (26) . The remaining seven, rs7909676, rs2394287, rs4459178, rs10997307, rs12258078, rs10822890 and rs713250, spanning about 38 kb, are encompassed by intron 9 of CTNNA3, which consists of 18 exons ( Fig. 2A and C ). The allelic P-values of these seven SNPs in the two sample sets, Exploratory and Validation, are presented in Table 2 , and marker information on them is summarized in Table 3 . The genotypic and allelic distributions are presented in the Supplementary Material, Table S1 .
To examine the gender-specific effects of the seven CTNNA3 SNPs on LOAD, we additionally performed joint analysis regarding gender (Table 2) . For this analysis, female and male allelic contingency tables were combined for the Exploratory and Validation sets, respectively (Supplementary Material, Table S1 ). x 2 tests based on the combined 2Â2 allelic contingency tables and calculation of the ORs with 95% CI were carried out. In the Exploratory set comprising both genders, none of these seven SNPs showed more significant association (allelic P-values ¼ 0.00005431 -0.0235) in comparison with the Exploratory set only including females (allelic P-values ¼ 0.00004614 -0.008). The ORs exhibited a tendency to decrease; for example, for SNP rs10822890, from 1.72 to 1.55. A similar trend for both the allelic Table 4 , in the All set, five (rs7909676, rs2394287, rs4459178, rs10822890 and rs713250) of the seven SNPs were statistically significant in females (allelic P-values ¼ 0.0009719 -0.00126). In the Negative-14 set, all seven SNPs exhibited more significant association with LOAD in females (allelic P-values ¼ 0.00001019 -0.002555). No evidence was found of association with any of the seven SNPs in males in any sample set.
For joint analysis concerning gender, female and male contingency tables (2 Â 2) with the allelic distributions were combined for the All, Negative-14 and Positive-14 sample sets, respectively (Supplementary Material, Table S2 ). Allelic P-values and ORs (95% CI) derived from the combined contingency tables were used to evaluate the gender-specific effects on LOAD (Table 4 ). This analysis revealed that in the All set including both genders, the ORs of significant SNPs (rs7909676, rs10822890 and rs713250) tended to be lower, compared with those in the female All set; for example, from 1.23 to 1.11 for SNP rs713250. A similar decreasing tendency for ORs of significant SNPs (rs7909676, rs2394287, rs4459178, rs10997307, rs12258078, rs10822890 and rs713250) in the Negative-14 set including both genders was also observed in comparison with those in the female Negative-14 set; for example, from 1.42 to 1.24 for SNP rs10822890.
Multiple logistic regression analysis, involving APOE-14, gender, age, the seven replicated SNPs on CTNNA3 and their interactions as independent variables, was performed to assess the potential effects of these variables on the association with LOAD, using 2762 subjects [LOAD, 1313 (female, 949; male, 364); controls, 1449 (female, 877; male, 572)] (Table 5) . In this analysis, the subjects used were not sub-grouped as to gender and/or carrier status of the APOE-14 allele. Initially, we carried out multiple logistic regression analysis with a forward stepwise method without interaction terms to elucidate which variables explained an association with LOAD independently. Model 1 in Table 5 Following this primary analysis, we further assessed second-order interaction terms created by the four significant risk factors including the SNP rs713250 (Model 2 in Table 5 ). Six interactions were tested by means of a forward stepwise method in addition to APOE-14, gender, age and the SNP rs713250. It was demonstrated that the SNP rs713250 exhibited significant interaction with the female gender in a dose-dependent manner as to the allele C [TC_female, OR (95% CI) ¼ 1.68 (1.12 -2.54); CC_female, OR (95% CI) ¼ 2.57 (1.59 -4.17)].
Linkage disequilibrium and case -control haplotype analyses
To reveal genetic relationship between each significant SNP on CTNNA3, linkage disequilibrium (LD) and haplotype estimation analyses were performed. For these analyses, we used four sample sets (All as the overall sample set, and Negative-14, Positive-14 and 13 Ã 3 as sub-sample sets) after being sub-grouped as to gender (Table 1) . From the Japanese HapMap genotype data (JPT), these SNPs were found to be encompassed by a highly structured LD block extending about 80 kb from 68.10 to 68.18 Mb (Fig. 2B ). They were in strong LD: the robust LD block structures did not differ between females and males or between LOAD and controls in any sample set (Supplementary Material, Fig. S1 ). Four haplotypes were estimated in each LD block consisting of the seven SNPs: three major haplotypes (frequency . Table 6 ). H1 exhibited the highest frequency (range 0.4363 -0.5356) and H4 the lowest (range 0.0084 -0.031). Haplotypes H1, H2 and H3 were always estimated with the expectation-maximization (EM) algorithm in the four sample sets examined. Haplotype H4 was not inferred in either Negative-14 or 13 Ã 3 consisting of male subjects. 
0.1), [H1]C-A-T-T-T-A-T, [H2]A-G-C-C-G-G-C and [H3]A-G-C-T-T-G-C, and one minor haplotype, [H4]C-A-T-T-T-A-C (
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Human Molecular Genetics, 2007, Vol. 16, No. 23 Because multiple SNPs may increase the risk of LOAD in combination, we carried out a case -control haplotype analysis (Table 6 ). In the All set, haplotypes H1 (permutation P-value ¼ 0.0029) and H3 (permutation P-value ¼ 0.0043) exhibited significant association in females. In both the Negative-14 and 13 Ã 3 sets, haplotypes H1, H2 and H3 exhibited significance in females (permutation P-value H1 , H2 , H3). In the All, Negative-14 and 13 Ã 3 sets, the frequency of haplotype H1 was decreased in LOAD, suggesting it is a protective haplotype for LOAD. On the other hand, haplotypes H2 and H3 were increased in LOAD, implying that they are risk haplotypes for LOAD. In males, each haplotype showed no significant difference in any sample set.
Of the four sample sets of females, three showed significant association in global tests: All (global permutation P-value ¼ 0.0006), Negative-14 (global permutation P-value ¼ 0.0008), and 13 Ã 3 (global permutation P-value ¼ 0.001). We did not detect significance in any haplotype in the female sub-sample set Positive-14 (global permutation P-value ¼ 0.3323).
Relationship between the Ab40/42 ratio and genetic variation on CTNNA3
The levels of plasma Ab40 and Ab42 and their ratio (Ab40/ 42) were compared between LOAD patients (N ¼ 456) and control subjects (N ¼ 147) within different gender groups (Fig. 3A -C) . The Mann -Whitney U-test was adopted as a non-parametric method for this analysis. In both the female and male groups, the Ab40 levels ( Fig. 3A) and Ab40/42 ratio (Fig. 3C) were significantly higher in LOAD in comparison with those in controls. The Ab42 levels were significantly lower in LOAD compared with those in controls (Fig. 3B) . 
To determine whether or not the difference in the Ab40/42 ratio between LOAD and the controls is due to the SNPs identified here, two-way ANOVA was performed across diagnosis (LOAD and control) and three genotypic groups (major homozygotes, heterozygotes and minor homozygotes) within different gender and their combined groups (Fig. 3D -F) . SNP rs713250 was used as a representative of the seven associated SNPs because it showed the most significant association with LOAD on Mantel -Haenszel test (allelic P-value MH-F ¼ 0.000005945), as shown in Table 2 . The logtransformed Ab40/42 ratio values [log 2 (Ab40/42 ratio þ 1)] were used in this analysis. Before two-way ANOVA, the Kolmogorov -Smirnov (KS) normality test and Bartlett's test for equal variances were performed for the each dataset as to gender. Almost every sub-group examined passed the KS normality test. Both the female -male (Fig. 3D) and female (Fig. 3E) groups passed the Bartlett's test, but not the male group (Fig. 3F , P ¼ 0.01178). Through two-way ANOVA, a significant effect of diagnosis was observed for every group (P-values ,0.0001). However, we did not detect any genotype-dependent effect of this SNP on the Ab40/42 ratio, and no interaction between the SNP, Ab40/42 ratio and diagnosis.
DISCUSSION
In this study, we extended our previous work on chromosome 10q (26) , and thoroughly reanalyzed the genotype data for 1140 SNPs in order to discover gender-related genetic loci for LOAD. In a single SNP-based case -control study, we found seven SNPs on CTNNA3 showing genetic association with LOAD in females with the APOE-13 Ã 3 genotype or without the APOE-14 allele. Furthermore, multiple logistic regression analysis revealed that one (SNP rs713250) of these seven SNPs directly interacted with the female gender, but not with the male gender, and did not show any interaction with the APOE-14 allele at all. These are the first findings constituting evidence that CTNNA3 may affect the development of sporadic LOAD through a novel female-specific mechanism independent of the APOE-14 allele. We consider the genetic association identified here to reflect one single signal. The reasons are: (1) the seven significant SNPs span only 38 kb and are clustered in intron 9 of CTNNA3 ( Fig. 2A  and C) , which suggests a multiple-hit genomic region of SNPs associated with LOAD; (2) solid linkage disequilibrium was observed between all of these seven SNPs (D 0 . 0.9) (Supplementary Material, Fig. S1 ); and (3) the associated region was encompassed by a tight structured LD block extending 80 kb (Fig. 2B) .
Janssens et al. (29, 30) cloned full-length CTNNA3 cDNA as a novel member of the a-catenin gene family and determined its genomic structure. CTNNA3 contains 18 exons and spans (32 -37) . In the first report (32) , it was demonstrated that two SNPs located in intron 13 of CTNNA3 are associated with familial LOAD with high levels of plasma Ab42, which was used as an intermediate phenotype related to AD. These intronic SNPs, spanning 423 bp, are rs12357560 and rs7070570: the former lies 1174 bp upstream, and the latter 1597 bp downstream from exon 14, respectively. They are in strong LD: D 0 ¼1 in all four populations, CEU, CHB, JPT and YRI, used in the HapMap project (38) . A genotypedependent correlation between SNP rs7070570 and the plasma Ab42 level has also been detected: the major homozygote (TT) is associated with the highest level of Ab42, the heterozygote (TC) with an intermediate level and the minor homozygote (CC) with the lowest level (32). Martin et al. (34) . found that SNP rs7074454 located in intron 13 of CTNNA3, lying 355 bp upstream from SNP rs7070570, was significantly associated with both familial and sporadic cases of LOAD. Non-synonymous SNP rs4548513 (AGC ! AAC, Ser596Asn) located in exon 13 of CTNNA3, lying 175 721 bp upstream from SNP rs7070570, has been shown to be associated with familial AD (37) . All of these four SNPs, rs7070570, rs12357560, rs7074454 and rs4548513, lie in a genomic region extending from exons 13 to 14 ( Fig. 2A) , which has been shown to be located within a large LD block spanning around 310 kb (67.43 -67.74 Mb) Fig. S2 ). They have a tendency to exhibit selective association with familial rather than sporadic LOAD (32, 35, 37) . Therefore, it is likely that the large LD block region contributes to a specific form of familial LOAD in Caucasians. We also assessed these four SNPs and SNPs neighboring them in our Japanese sporadic LOAD subjects, however, none of these SNPs exhibited significant association (data not shown). In the genomic The SNP order, from left to right, is as follows: rs7909676, rs2394287, rs4459178, rs10997307, rs12258078, rs10822890 and rs713250. Haplotypes with frequencies ,0.01 in both LOAD and control subjects. region including the four SNPs, different LD block structures were observed in Japanese and CEPH subjects ( Fig. 2B and Supplementary Material, Fig. S2 ). As one of the reasons why reproducible association could not be detected for these four SNPs, we mainly consider that an ethnic difference may exist. High-level gene expression of CTNNA3 is detected predominantly in heart and testis, and low-level expression in several tissues including brain (29) . Coimmunoprecipitation analysis revealed that CTNNA3 binds directly to b-catenin in both a human cell line transfected with CTNNA3 cDNA, and heart and testis tissue extracts of mouse (30) . b-Catenin forms a complex with presenilin 1 (PSEN1) (31,39,40 (41), resulting in sustained loss of Wnt/b-catenin signal transduction, which is probably followed by the onset and development of AD (42, 43) . Although, at present, there is no direct evidence suggesting that CTNNA3 interacts with PSEN1, it is assumed that their genetic polymorphisms or combinations in CTNNA3 may have a negative influence on the Wnt/b-catenin signaling pathway, leading to potential involvement in the pathogenesis of AD. In this study, it was clarified that seven intronic SNPs on CTNNA3 were significantly and reproducibly associated with sporadic female cases of LOAD without the APOE-14 allele. Intronic variants are considered to have the potential to directly affect gene-expression levels in some cases (44) ; therefore, we performed quantitative real-time RT -PCR analysis of CTNNA3 using the postmortem brains of 19 neuropathologically-confirmed LOAD cases and 22 control ones. Two-way ANOVA revealed that there was no statistically significant interaction between the CTNNA3 expression level, the associated SNPs identified here and the diagnosis (data not shown). Additionally, although a genotypedependent transition effect on the plasma Ab42 level was observed for intronic SNP rs7070570 by Ertekin-Taner et al. (32) , it was found that none of these SNPs influence the plasma levels of Ab peptides (Fig. 3D -F) .
H1]C-A-T-T-T-
However, interestingly, by means of a search of a public genome database, the Database of Genomic Variants (http:// projects.tcag.ca/variation/), we discovered that there is copy number variation (CNV) (45) in the genomic region comprising the seven associated SNPs on CTNNA3: variation ID 3807 at Locus 2128, which was detected in a Japanese subject (ID, NA18973) ( Fig. 2A) . CNV, i.e. deletion, insertion and duplication with .1 kb in length of the genomic sequence (46), rather than SNP could cause phenotypic diversity and complex diseases in humans by altering the gene dose or disrupting the coding or regulatory sequences of genes, and may account for the LOAD susceptibility. Regarding our LOAD subjects, we did not examine the presence or absence of CNV within CTNNA3. Therefore, in a further study, it is very important to determine whether or not CNV in CTNNA3 is associated with LOAD.
Recently, in LOAD families, notable evidence was obtained suggesting a maternal parent-of-origin effect on chromosome 10q between microsatellite markers D10S1233 (44.05 Mb) and D10S1225 (64.43 Mb) with a non-parametric LOD score .1.0: the highest LOD score of 3.73 was seen for microsatellite marker D10S1221 (57.20 Mb) (27, 28) . Moreover, it was found that CTNNA3 is subject to genomic imprinting with cell-type specificity in placental tissues: biallelic and monoallelic (maternal-allele) expression is observed in extravillus and villus trophoblasts, respectively (47) . Mouse Ctnna3 (Clone ID 4933408A16 on FANTOM2), orthologous to human CTNNA3, has been deposited as a maternal imprinting gene on chromosome 10 in the Expression-based Imprint Candidate Organizer DataBase (48; EICO DB, http:// fantom2.gsc.riken.jp/EICODB/imprinting/), provided by RIKEN (Japan). These findings led us to examine whether or not CTNNA3 shows allele-specific expression caused by a molecular mechanism such as genomic imprinting in the brain. We conducted real-time RT -PCR analysis with allele-specific amplification using postmortem human brains heterozygous for non-synonymous SNP rs4548513 in exon 13 [LOAD, 7 (female:male ¼ 3:4); control, 8 (female: male ¼ 3:5)]. Unexpectedly, biallelic expression was detected in brain tissues, and there was no significant difference between LOAD patients and control subjects in the expression level of CTNNA3 (data not shown). Since as in placental tissues, as described above, it is possible that cell-type dependent imprinting for CTNNA3 may occur in the brain, further expression analysis should be carefully carried out using homogeneous populations of specific cells from brain tissues. Now genome-wide prediction and the discovery of imprinted genes have progressed (49, 50) , and 600 (2.5%) of 23 788 annotated autosomal genes have been found to be potentially imprinted in the mouse genome by computational estimation: 384 (64%) of these candidate-imprinted genes show maternal-allele expression (50) . It is expected that failure of imprinted gene expression in the human brain may lead to cognition and behavior defects such as Alzheimer's disease, schizophrenia, the bipolar affective disorder and epilepsy (51 -53) . Therefore, it is important and interesting to actively examine imprinted genes present in the genetic linkage region of LOAD.
MATERIALS AND METHODS
Subjects
The Japanese Genetic Study Consortium for AD (JGSCAD) was organized in 2000, and blood samples were collected to survey risk genes for LOAD by means of a genome-wide association study. All individuals included in this study were Japanese. Probable AD cases met the criteria of the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders. Control subjects who had no signs of dementia and lived in an unassisted manner in the local community were also recruited. Age at onset (AAO) is here defined as the age at which the family and/or individuals first noted cognitive problems during work or in daily activities. The Mini-Mental State Examination (MMSE), and Clinical Dementia Rating and/or the Function Assessment Staging were used for the evaluation of cognitive impairment: MMSE was used for almost every subject.
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Human Molecular Genetics, 2007, Vol. 16, No. 23 The basic demographics of the LOAD patients and nondemented control subjects are presented in Table 1 1%) ], which is referred to as overall sample set All in this study, were used to discover gender-related loci associated with LOAD on chromosome 10q: information on these subjects was also presented in our recent paper, Kuwano et al. (26) . The mean AAO + standard deviation (SD) in the 1526 LOAD patients was 73.5 + 6.6 (range 60-93). The mean age at examination (AAE) + SD of the control subjects was 73.1 + 7.8 (range 60 -96). There was no significant difference between AAO in LOAD patients and AAE in control subjects with the unpaired Student's t-test (P-value ¼ 0.1239). The mean MMSE score in the 1526 LOAD patients was 16.5 (SD 7.0), which was significantly lower (P-value with unpaired Student's t-test ,0.0001) than that in the 1666 controls (mean + SD 28.0 + 1.8 Ã 3 in the exploratory sample set, as shown in Table 1 ). We used 1140 SNPs that were shown to be actually polymorphic in the Japanese population and showed P-values .0.05 with the exact tests; mean intermarker distance + SD, 40.5 + 96.7 kb; 95% CI, 34.9 -46.1 kb.
Genomic DNA was extracted from peripheral blood with a QIAamp DNA Blood Maxi Kit (Qiagen, Duseldorf, Germany) and examined fluorometrically with a PicoGreen dsDNA quantification kit (Molecular Probes, California, USA). SNP genotyping of individual samples was performed with an ABI PRISM 7900HT instrument using TaqMan technology, and TaqMan SNP Genotyping Assays were purchased from Applied Biosystems (California, USA).
Case-control study
To discover gender-related genetic loci on chromosome 10q (60 -107 Mb on NCBI build 35.1), allelic association was assessed by means of the x 2 test based on a 2Â2 contingency table in comparison with allele frequencies in LOAD patients and control subjects within different gender groups. For screening, two independent sample sets, Exploratory and Validation, comprising case -control subjects with APOE-13 Ã 3 were first used after being stratified as to gender (Table 1) . Sample set Exploratory comprising 363 LOAD patients and 337 control subjects was genotyped (26) , and SNPs showing significant association (allelic P-value ,0.01) were then subjected to further examination using another sample set, Validation, comprising 336 LOAD patients and 372 control subjects. Multistage, including two-stage, genotyping designs for large-scale association surveys have been proved to be practically as well as theoretically effective for identifying common genetic variants that predispose to human disease (54 -58) . Therefore, we considered that replication in both the Exploratory and Validation sample sets implicates an association of particular SNPs with LOAD.
Subsequently, for stratified analysis we increased the number of subjects and constructed an overall sample set, All. Furthermore, to construct three sub-sample sets, overall sample set All was stratified as to the APOE carrier status: Negative-14, APOE-1 2 Ã 2, 2 Ã 3 and 3 Ã 3; 13 Ã 3, APOE-1 3 Ã 3; Positive-14, APOE-1 2 Ã 4, 3 Ã 4 and 4 Ã 4 ( Table 1 ). The sample numbers for LOAD patients and controls in All, Negative-14, 13 Ã 3 and Positive-14 were 1526 and 1666, 749 and 1378, 699 and 1243, and 777 and 288, respectively. These four sample sets were used for the x 2 test after being sub-grouped as to gender.
Case -control haplotype analysis with significant SNPs was also performed using the following sample sets: All, Negative-14, 13 Ã 3 and Positive-14. These four sample sets were used after being stratified as to gender.
Ab40 and Ab42 quantification
For Ab40 and Ab42 quantification, 603 subjects consisting of 456 LOAD patients (female, 332; male, 124) and 147 control subjects (female, 95; male, 52) were used. They are included in the All set. The sandwich enzyme-linked immunosorbent assay (59 -61) was used to specifically quantify whole plasma Ab species. The standardization, sensitivity and specificity of the method were described in a previous paper (61) .
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Briefly, microplates (Immunoplate I; Nunc, Rockilde, Denmark) were pre-coated with monoclonal BNT77 (IgA isotype specific for Ab11 -16) and then sequentially incubated for 24 h at 48C (100 ml of whole plasma/well), followed by 24 h incubation at 48C with horseradish-peroxidaseconjugated BA27 (anti-Ab1-40, specific for Ab40) or BC05 (anti-Ab35 -43, specific for Ab42). Color was developed with 3,3 0 ,5,5 0 -tetramethylbenzidine and evaluated at 450 nm with a microplate reader (Molecular Devices, CA). Synthetic Ab40 and Ab42 (Sigma, St Louis, MO) of known concentration (estimated from the amino acid composition) were used as standards. The plates were normalized as to each other by inclusion of three standard plasma samples on all plates.
Statistical analysis
Allele frequencies were calculated by allele counting. To evaluate deviation from the HWE of each SNP marker, we carried out an exact test (62) based on the probability of occurrence of genotypic contingency tables with fixed total numbers of alleles within each sample set (LOAD patients and controls included in two screening sets, Exploratory and Validation). For single SNP case -control analysis, the allelic distributions in LOAD patients and controls were compared by means of x 2 tests via standard 2Â2 contingency tables. Evidence of replication, rather than multiple testing corrections, was used to evaluate the significance of associated SNPs. To comprehensively assess the reproducible SNPs, we conducted a Mantel -Haenszel test, where Exploratory and Validation samples in our case -control study were considered as the strata (63) , and computed pooled ORs with 95% CI and P-values from Mantel -Haenszel statistics (Statcel 2; OMS, Tokyo, Japan). Estimation of haplotypes and their frequencies was carried out for LOAD patients and controls separately by the maximum-likelihood method from unphased diploid genotype data using an EM algorithm (64) with the following parameters: iteration counter, 5000; conversion criterion, 0.000001. To assess the differences in haplotype distribution between LOAD patients and controls, a permutation test (65) was performed. In this test, all permutation P-values were empirically computed using 10 000 iterations of random sampling with fixed total numbers of both LOAD and control subjects. OR (95% CI), as an estimate of the relative risk of disease, of each marker or haplotype was calculated from a 2Â2 contingency , gender (male/female), age and significant SNPs identified here (major-allele homozygote/heterozygote/ minor-allele homozygote) on the risk for LOAD as well as their second-order interaction terms. The strength of association between these variables and disease status (control/ LOAD) was evaluated with ORs with 95% CI, based on Wald statistics. We examined the four variables by means of a two-step multiple logistic regression analysis according to Akazawa et al. (68) . In order to examine which variables explain an association with LOAD independently, we initially carried out stepwise logistic regression analysis (forward selection method) without interaction terms. A significance level of 0.05 was used to enter a variable in the model. Through this analysis, the following multiple logistic regression model was fitted (Model 1 in Table 5 ): log(P/ (1 2 P) 
where P denotes the probability of having LOAD, a is the intercept, b i represents the estimated parameters and Xj the independent variables (X1, APOE-14; X2, gender; X3, age; X4, SNP). We next analyzed the four variables including their second-order interaction terms (SNP_gender, SNP_APOE-14, SNP_age, gender_APOE-14, gender_age and age_APOE-14) by means of a forward stepwise regression method with a significance level of 0.05 for the inclusion of a variable in the model. As a result, the following model was fitted (Model 2 in Table 5 ): log(P/(1 2 P))
, where P denotes the probability of having LOAD, a is the intercept, b i represents the estimated parameters and Xj the independent variables (X1, APOE-14; X2, gender; X3, age; X4, SNP; X5, SNP_gender; X6, gender_APOE-14; X7, age_APOE-14). Subjects with undetermined SNP genotype data were omitted for multiple logistic regression analysis.
The Mann -Whitney U-test was applied to compare differences in the levels of Ab40 and Ab42, and their ratio (Ab40/42) between LOAD patients and controls (Prism 4.0b; GraphPad Software, CA, USA). After Bartlett's test for the homogeneity of variances (Statcel 2) and the KS normality test (Prism 4.0b), the effects of three SNP genotypes (minor-allele homozygotes, heterozygotes and major-allele homozygotes) in three sub-groups stratified as to gender (female -male mixture, female or male) were examined as to levels of the plasma Ab40/42 ratio using two-way ANOVA (Prism 4.0b). To create more normally distributed datasets, the Ab40/42 ratio was subjected to log transformation [log 2 (Ab40/42 ratio þ 1)] before the two-way ANOVA.
The statistical significance was set at P , 0.05.
